Project Grant 2537730
Award Date 7/1/26
Completion Date 6/30/27
Dollars Obligated $305K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30318, USA
Similar Awards
- Federal Grant Award Summary Primary Bioscience, Inc. received a $305,000 Small Business Technology Transfer (STTR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) effective July 15, 2025, with a completion date of June 30, 2026. The company is developing an ultra-sensitive biosensor capable of single-molecule protein analysis and sequencing. The technology integrates a nanopatterned chip with a proprietary amino acid and...
- Federal Grant Award Summary Amygo Solutions LLC received a $304,643 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) effective July 1, 2026, through August 31, 2027. The company will develop and validate a novel blood test diagnostic for detecting transthyretin amyloidosis, a progressive protein misfolding disorder affecting approximately 500,000 individuals in the United...
- Federal Project Grant Summary Phase, Inc. received a $304,761 National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I award under the Technology, Innovation, and Partnerships program (CFDA 47.084) effective June 1, 2026, through May 31, 2027. The project advances high-resolution 3D printing technology for polydimethylsiloxane (PDMS) microfluidic devices—commonly referred to as "labs on a chip"—which are essential tools for disease research, drug testing, and...
- Federal Grant Award Summary Avant Genomics, Inc. received a $305,000 Small Business Innovation Research (SBIR) Phase I project grant from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), awarded October 1, 2025, with a completion date of September 30, 2026. The company is developing an automated microfluidic-based system that streamlines bisulfite conversion, a critical and time-consuming step in preparing circulating tumor DNA...
- Federal Project Grant Award Summary Resolet Inc. received a $305,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (TIP) under CFDA 47.084, effective July 1, 2026, through June 30, 2027. The company is developing a compact, low-field magnetic resonance relaxometry sensor operating at 0.1 Tesla for measuring iohexol concentration in blood samples to assess kidney function. This benchtop...
- Federal Grant Award Summary Particle4X, Inc. received a $304,972 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) effective October 1, 2025, through September 30, 2026. The company is developing a compact, real-time inline monitoring sensor system for injectable drug manufacturing that integrates digital inline holography (DIH) and deep learning algorithms to simultaneously...
- Federal Grant Award Summary Gelastomerics LLC received a $305,000 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084), effective May 1, 2025 through April 30, 2028. The project focuses on research and development to establish the technical and commercial viability of a novel hydrogel elastomer technology designed to provide intrinsic lubricity for medical device applications. This...
- Federal Project Grant Award Summary Spectral Therapeutics, Inc. received a $304,950 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) on July 1, 2026, with completion anticipated by March 31, 2027. The company is developing a novel, ultra-miniaturized drug discovery platform that integrates III-V semiconductor laser particles as spectral barcodes into polymer beads for...
- Federal Grant Award Summary Nanoplasmonics LLC received a $304,780 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on June 1, 2025, to develop breakthrough sensor technology for mycotoxin detection in the food supply chain. The project, based in Colorado Springs, Colorado, will be completed by May 31, 2026. The primary deliverable is an innovative detection system that...
- Federal Project Grant Award Summary Synlibris, Inc. received a $304,957 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) effective July 1, 2026, through June 30, 2027. The project develops a continuous evolution platform technology designed to accelerate the discovery of genetic solutions for high-yield protein biomanufacturing. The core innovation utilizes an orthogonal DNA...